report by BlackRock
Results for ""
Policy and Regulatory Commentary
Facing heightened uncertainty, the Fed delivers another hike
This piece is approved to use with clients.
The Fed has raised rates by 300 basis points since June, a nearly unprecedented pace of tightening done to combat persistent inflation amid continued strength in the labor market and consumer spending. But markets are worried it will go too far, triggering a recession.
Policy and Regulatory Commentary
Fed rate hikes will continue until inflation improves
This piece is approved to use with clients.
Nuveen's Chief Investment Strategist, Brian Nick, provides his thoughts on the Fed meeting.
Policy and Regulatory Commentary
The Fed’s “summer of 75” continues, despite growth risks
This piece is approved to use with clients.
A higher-than-expected consumer price inflation report for June compelled the U.S. Federal Reserve to maintain its brisk pace of policy tightening. The U.S. economy is showing signs of slowing, which could lead the Fed to reduce its pace of rate increases in September.
Sustainable Investing
International Women’s Day: Women at the heart of the COVID-19 recovery
This piece is approved to use with clients.
We celebrate this year’s International Women’s Day whilst at a critical juncture for global gender equality.Although recent years have seen progress on, for example, female presentation in leadership positions, the Covid-19 pandemic has laid bare and deepened already existing inequities
Sustainable Investing
2019–2020 Responsible Investing Engagement Report
This piece is approved to use with clients.
The 2019-2020 Responsible Investing Engagement Report chronicles Nuveen's active-ownership initiatives and the outcomes achieved over the past year.
Sustainable Investing
Influencing for good: 20 years of engagement
This piece is approved to use with clients.
The way investors conduct engagement has transformed. From a niche approach largely confined to mission-orientated investors, engagement is now a mainstream investor activity. The success of the Climate Action 100+ initiative in bringing together investors, representing close to US$40 trillion in assets, shows how far we have come.
Sustainable Investing
ESG Viewpoint – COVID-19 and the pharmaceutical industry
This piece is approved to use with clients.
Public trust in the pharmaceutical industry has eroded. The pandemic provides drug-makers a chance to begin re-building their reputation – but only if they prioritise socially responsible practices.